跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
GIVLAARI
Authorized
STANDARD
GIVLAARI
Alnylam Netherlands BV
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
f203fe8d93e83b50
Company
Alnylam Netherlands BV
Type
Standard
Approval Details
Approval Id
f203fe8d93e83b50
Drug Approval Canada Name
GIVLAARI
Product Name
GIVLAARI
Status
Marketed
Status Date
2020-12-01
Original Market Date
2020-12-01
Din
02506343
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Prescription
Ahfs
92:92.00
Atc Original
A16AX16 GIVOSIRAN
Atc Name
a 16 ax 16
Aig Number
0162538001
Company Name
Alnylam Netherlands BV
Company Address
Antonio Vivaldistraat 150, Amsterdam, --, Netherlands, 1083 HP
Company Detail Path
/organization/alnylam-netherlands-bv
Company Information
Pharmaceutical Company Name
Alnylam Netherlands BV
Country Name
Netherlands
Website
http://www.alnylam.com/alnylam-netherlands
Active Ingredients
GIVOSIRAN (GIVOSIRAN SODIUM)
189 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
f203fe8d93e83b50
Type
Standard
Back to Health Canada Approvals
GIVLAARI - Health Canada Drug Approval Details